GlobalData on MSN
BMS and Hengrui forge $15.2bn alliance for early-stage drugs
The two companies will trade the greater Chinese and US rights to certain programmes under their jurisdiction, while working in tandem to progress these assets.
Bristol Myers Squibb (BMS) will partner with Hengrui Pharma to co-develop 13 early-stage programs in oncology, hematology, and immunology, through a collaboration that could generate more than $15.2 ...
Bristol Myers Squibb has forged close ties with China's Hengrui Pharma, partnering across 13 programmes in oncology, ...
Bristol Myers Squibb and Hengrui Pharma enter strategic agreements to advance innovative medicines across oncology, haematology, and immunology: Princeton, New Jersey Wednesday, M ...
Hengrui Pharma ("Hengrui") (600276.SH; 01276.HK) and Bristol Myers Squibb ("BMS") today announced the companies have entered into global strategic collaboration and license agreements to advance a ...
Get information about infrastructure and facilities provided by BMS College for Women, Bangalore, Bangalore on Edugraph ...
Forbes contributors publish independent expert analyses and insights. Kevin Kruse covers leadership development & emotional intelligence. This voice experience is generated by AI. Learn more. This ...
A new AI-powered battery management system can squeeze thousands of extra miles out of EV batteries.
Company's shares jump in Hong Kong and Shenzhen after tie-up that bolsters China's growing drug innovation profile Jiangsu ...
AIIR Intelligent HVAC (AIIR), a leading provider of AI-powered heating and cooling solutions, today announced a strategic partnership with Copeland, a global leader in compression technologies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results